Abstract

Mammographic test sets are a simulation-based training methodology for radiologists to assess and improve their performance. However, while test-set records have indicated over-time improvements in participants' performance within the tests, little is known about how those improvements translate into breast-screening readers’ performance in the clinic. This study investigated how the performance of readers who completed test-set training in the BreastScreen Reader Assessment Strategy (BREAST) platform have evolved in comparison to readers who have no history of test-set participation. Investigating 10-year clinical audit data of 46 breast screening readers in New South Wales, Australia indicated that BREAST readers improved their positive predictive value (PPV) (p=0.001) in association with their testset participation. They also had higher detection rates for invasive cancers (p=0.01), ductal carcinoma in situ (DCIS) (p=0.03), and the detection rate of all cancers and DCIS (p=0.01). In comparison, non-BREAST readers improved their recall rate in subsequent screens (p=0.03) and PPV (p=0.02). In conclusion, test-set participation is linked to enhanced capability of cancer detection, which can be due to the high proportion of cancer cases in the test sets in comparison to normal practice.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.